RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023 

Rhea-AI Summary

RxSight, Inc. will report financial results for Q3 2023 on November 9, 2023. The conference call will be held at 1:30 p.m. PT / 4:30 p.m. ET. Participants can register for the call and access the webcast at https://investors.rxsight.com/.

Positive

• Investors can gain insights into RxSight's financial performance for Q3 2023, which may positively impact the stock price.

Negative

• No negative takes found.

ALISO VIEJO, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the third quarter 2023 after the market close on Thursday, November 9, 2023. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Participants may register for the call here and listen through a live and archived webcast of the event available for one year at https://investors.rxsight.com/. While not required, it is recommended that participants join ten minutes prior to the event start time to ensure the necessary audio applications are downloaded and installed. Instructions are provided (including a dial-in option).

About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight^® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens^® (LAL^®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
ir@rxsight.com

FAQ

When will RxSight report its financial results for Q3 2023?

RxSight will report its financial results for Q3 2023 on November 9, 2023.

What time will the conference call begin?

The conference call will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

How can participants access the webcast of the event?

Participants can access the webcast of the event at https://investors.rxsight.com/.

Is it necessary to join the call early?

While not required, it is recommended that participants join ten minutes prior to the event start time to ensure the necessary audio applications are downloaded and installed.